Search
    Skip to main content
    Advertisement

    AbbVie

    1. Business
    2. Biotech
    3. AbbVie
    Approvals extend use of Roche, AbbVie drugs in lymphoma pharmaphorum06:23Blood Cancer Roche Pharma
    FDA approves AbbVie’s Epkinly to treat follicular lymphoma Pharmaceutical Technology09:45FDA Cancer Treatment Blood Cancer
    AbbVie Inc. (ABBV) is attracting investor attention: Here is what you should know Zacks10:01Pharma
    AbbVie Inc. (ABBV) is a trending stock: Facts to know before betting on it Zacks10:02Pharma
    How strong is AbbVie's immunology franchise after humira's loe? Zacks08:47Global Stock Markets Pharma Business (US)
    Here's how neuroscience drugs aided AbbVie's top-line growth in Q3 Zacks10:44Cosmetic Surgery Pharma Biology
    AbbVie scores Canadian reimbursement recommendations for blockbuster ulcerative colitis drug skyrizi Benzinga11:24NYSE Pharma Stock Markets
    BioMed X announces neuroscience research partnership with AbbVie Manufacturing Chemist04:48Pharma Biotech Biology
    Global Pharma company with big site in Mayo scoop industry awards The Mayo News11:40Pharma County Mayo Rep. of Ireland
    AbbVie reports Phase III study results of atogepant Clinical Trials Arena06:21Pharma Biotech

    Latest News

    In the last 7 days
    AbbVie revs up Skyrizi spending to top TV ad totals in November, edging out J&J’s Tremfya FiercePharma14:08 5-Dec-25
    Could Buying AbbVie Today Set You Up for Life? The Motley Fool09:37 4-Dec-25
    How Strong Is AbbVie's Immunology Franchise After Humira's LOE? Zacks08:47 4-Dec-25
    AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know Zacks10:01 3-Dec-25
    AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment… PR Newswire (Press Release)08:20 2-Dec-25
    AbbVie reports Phase III study results of atogepant Clinical Trials Arena06:21 2-Dec-25
    AbbVie’s atogepant illustrates migraine therapy label expansion potential European Pharmaceutical Review09:46 1-Dec-25
    AbbVie to Present Phase 3 ECLIPSE Data Demonstrating Atogepant (AQUIPTA®) Superiority Over… PR Newswire (Press Release)04:09 1-Dec-25
    In the last month
    AbbVie Scores Canadian Reimbursement Recommendations For Blockbuster Ulcerative Colitis Drug Skyrizi Benzinga11:24 28-Nov-25
    Global Pharma company with big site in Mayo scoop industry awards The Mayo News11:40 27-Nov-25
    BioMed X announces neuroscience research partnership with AbbVie Manufacturing Chemist04:48 27-Nov-25
    AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights Zacks11:49 26-Nov-25
    Is AbbVie Stock Outperforming the Nasdaq? Barchart10:12 26-Nov-25
    AbbVie short film showcases ‘Second Winds’ of life after CLL diagnosis FiercePharma12:50 25-Nov-25
    BioMed X Announces New Neuroscience Research Collaboration in the USA Biotech, B3C newswire00:11 25-Nov-25
    AbbVie to Present at the Piper Sandler 37th Annual Healthcare Conference PR Newswire (Press Release)08:01 24-Nov-25
    The Zacks Analyst Blog JPMorgan, Netflix, AbbVie and Ohio Valley Banc Zacks06:17 24-Nov-25
    Assessing AbbVie’s Share Value After Stock Climbs 31.7% in 2025 Simply Wall St22:04 23-Nov-25
    FDA Approval of EPKINLY Combo Might Change the Case for Investing in AbbVie (ABBV) Simply Wall St03:00 22-Nov-25
    Top Research Reports for JPMorgan Chase, Netflix & AbbVie Zacks17:27 21-Nov-25
    2 Dividend Stocks to Hold Through Any Market Cycle 24/7 Wall St.12:32 19-Nov-25
    Vitiligo Market Analysis and Forecasts 2025-2035 Featuring Abbvie, Incyte, Amgen, Pfizer,… Business Wire (Press Release)11:29 19-Nov-25
    AbbVie Stock Rebounds After Q3 Dip: Time to Buy, Hold or Sell? Zacks10:12 19-Nov-25
    AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It Zacks10:02 19-Nov-25
    FDA approves AbbVie’s Epkinly to treat follicular lymphoma Pharmaceutical Technology09:45 19-Nov-25
    Approvals extend use of Roche, AbbVie drugs in lymphoma pharmaphorum06:23 19-Nov-25
    FDA Greenlights AbbVie And Genmab's Epkinly Combo For Relapsed Or Refractory Follicular Lymphoma RTT News04:09 19-Nov-25
    AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for… AbbVie (Press Release)12:49 18-Nov-25
    Here's How Neuroscience Drugs Aided AbbVie's Top-line Growth in Q3 Zacks10:44 18-Nov-25
    AbbVie parts ways with Calico Longevity Technology08:37 17-Nov-25
    AbbVie Stock Falls 4% -- What Investors Need to Know The Motley Fool07:53 17-Nov-25
    Filmmaker helps AbbVie spread the word about leukaemia pharmaphorum07:27 17-Nov-25
    AbbVie Partners with Award-Winning Filmmaker on Film About the Dynamic and Resilient Lives of… PR Newswire (Press Release)12:33 14-Nov-25
    AbbVie Announces 20 Recipients of Migraine Career Catalyst Award™ PR Newswire (Press Release)08:33 13-Nov-25
    Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, AppLovin, Autozone, Booking … 24/7 Wall St.08:12 13-Nov-25
    AbbVie exits alliance with Alphabet biotech Calico; report pharmaphorum07:47 13-Nov-25
    AbbVie Shares Rise To Intraday High After Key Trading Signal Benzinga15:14 12-Nov-25
    How Much Did Skyrizi and Rinvoq Drive AbbVie's Q3 Performance? Zacks13:03 12-Nov-25
    STAT Plus: AbbVie cuts ties with Google-backed longevity company, lays off scientists STAT10:52 12-Nov-25
    See Which Of The Latest 13F Filers Holds ABBV Nasdaq10:23 10-Nov-25
    QurAlis Announces Appointment of Manoj Malhotra, M.D., as Chief Medical Officer Business Wire (Press Release)07:48 10-Nov-25
    AbbVie deepens oncology partnership with Asan Medical Center Korea Biomedical Review02:11 10-Nov-25
    Capsida Biotherapeutics emerges from stealth with $140m Longevity Technology13:45 7-Nov-25
    view more headlines
    5 Dec 14:08

    AbbVie News

    NewsNow aims to be the world's most accurate and comprehensive aggregator of AbbVie news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
    Read more

    Biotech Top Stories

    STAT Plus: Fulcrum study suggests improved efficacy for higher dose sickle cell pill STAT12:29
    Skuast-K awarded E-Yuva centre to drive Agri-Biotech innovations Rising Kashmir22:07
    China's Kelun-Biotech licenses cancer treatment to Crescent Biopharma Yahoo! US23:20
    India can build a $1.2-trillion bioeconomy by 2047 The Hindu Business Line19:39
    Ginkgo bioworks selected by pnnl to deliver a modular, high‑throughput phenotyping platform for … PR Newswire (Press Release)08:38

    Business Top Stories

    Here are 2 major Social Security changes retirees need to know heading into 2026 The Motley Fool20:26Social Security
    Social Security benefits won't be slashed in 2026. But here's when retirees may be looking at cuts The Motley Fool09:40Social Security
    Exclusive-How Netflix won Hollywood's biggest prize, Warner Bros Discovery Yahoo! US20:03Netflix Streaming Warner Bros
    'Lowest-probability outcome': Netflix's $72 billion deal for Warner Bros. Discovery stuns Wall… Yahoo! US10:38Netflix Streaming Warner Bros
    Better Artificial Intelligence stock: Palantir Technologies vs. Nvidia The Motley Fool15:47Palantir Nvidia AI
    The market is giving investors an unbeatable opportunity to buy this long-term Artificial Intelligence (AI) winner… The Motley Fool09:09Palantir Nvidia AI
    This artificial intelligence (AI) infrastructure stock could be the Nvidia of 2026 The Motley Fool15:16Nvidia Top Tech Brands AI
    Prediction: Nvidia stock is going to soar past $300 in 2026 The Motley Fool10:40Nvidia Top Tech Brands AI
    Gen Z shoppers are cutting their holiday budgets. Here's why. Yahoo! US08:05
    Nearly 4M U.S. Manufacturing jobs will open by 2033—but Gen Z won’t touch them All Work02:01
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.